Lebrahma Lifescience Private Limited
About Lebrahma Lifescience Private Limited
Data last updated:
Lebrahma Lifescience Private Limited was a private limited company based in Aurangabad, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 27 July 2020.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2020PTC342687. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Manoj Mahadeo Nagargoje and Dipak Tanaji Padwal.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Plno B1/7 Parmar Valley Ramgopal Nagar Padegaon, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2023, the company reported a revenue of ₹11,000. For the same year it recorded a net loss of ₹25,323 (net margin -230.2%) and EBITDA of -₹25,323 (EBITDA margin -230.2%).
Company details
Contact details
Lebrahma Lifescience Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlno B1/7 Parmar Valley Ramgopal Nagar Padegaon, Aurangabad, Maharashtra, India – 431001
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Lebrahma Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lebrahma Lifescience Private Limited
FY 2023 filings availableLebrahma Lifescience Private Limited reported revenue of ₹11,000 for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹11,000 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹25,323 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹25,323 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -230.2% | ||
| Net Profit Margin | -230.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Lebrahma Lifescience Private Limited, buy the company report.
Board of directors of Lebrahma Lifescience Private Limited
Lebrahma Lifescience has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Mahadeo Nagargoje | Director | 08 Oct 2021 | 5 Years 0 Months | As last reported |
| Dipak Tanaji Padwal | Director | 08 Oct 2021 | 5 Years 0 Months | As last reported |
| Santosh Shyamlal Jaiswal Also directs: Health4you Pharmaceutical Private Limited | Director | 27 Jul 2020 | 6 Years 3 Months | As last reported |
| Rahul Buvasaheb Bade | Director | 27 Jul 2020 | 6 Years 3 Months | As last reported |
Peer comparison
Lebrahma Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sri Krishna Sai Diagnostic and Research Institute Private Limited | ₹13,231 (FY 2024) | -69.0% | Hyderabad, Telangana, India | |||
| Totipotentrx Cell Therapy Private Limited | ₹13,207 (FY 2023) | -38.0% | Gurugram, Haryana, India | |||
| Sanctus Bio Private Limited | ₹13,070 (FY 2024) | 15.0% | Hyderabad, Telangana, India | |||
| Shri Siddhivinayak Cath Lab Private Limited | ₹11,576 (FY 2020) | -99.0% | Karad, Maharashtra, India | |||
| Dalhousie Square Medical & Research Centre Private Limited | ₹11,062 (FY 2025) | Kolkata, West Bengal, India | ||||
| Lebrahma Lifescience Private Limitedthis company | ₹11,000 (FY 2023) | -₹25,323 | -230.2% | Aurangabad, Maharashtra, India | ||
| Touchlabs Healthcare Private Limited | ₹10,532 (FY 2025) | -100.0% | Surat, Gujarat, India | |||
| Classic Apple Diagnostics Private Limited | ₹10,500 (FY 2024) | -99.0% | Nashik, Maharashtra, India | |||
| Om Shree Jan Kalyan Hospital Private Limited | ₹10,452 (FY 2025) | Bhojpur, Bihar, India | ||||
| Medulla Healthcare Private Limited | ₹10,000 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Advanced Gynae Lap Private Limited | ₹9,576 (FY 2024) | Bhubaneswar, Odisha, India |
To see the full peer comparison of Lebrahma Lifescience Private Limited, buy the company report.
Auditor
Lebrahma Lifescience Private Limited is audited by V.P. SHINDE & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.P. SHINDE & CO. | FY 2023 | 110129W |
Shareholding
The shareholding of Lebrahma Lifescience Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Lebrahma Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lebrahma Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lebrahma Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lebrahma Lifescience Private Limited has 1 active EPFO establishment as of Apr 01, 2024.
GST
Lebrahma Lifescience has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Lebrahma Lifescience Private Limited, buy the company report.
Recent activity
Lebrahma Lifescience Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Dipak Tanaji Padwal was appointed as Director on 08 Oct 2021.
Frequently asked questions
Lebrahma Lifescience has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Lebrahma Lifescience was a private limited company based in Aurangabad, Maharashtra, India. The company worked in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 27 July 2020 and is registered under CIN U85100MH2020PTC342687. The company has been struck off by the Registrar of Companies and is no longer operational.
Lebrahma Lifescience had 4 directors:
- Manoj Mahadeo Nagargoje - Director
- Dipak Tanaji Padwal - Director
- Santosh Shyamlal Jaiswal - Director
- Rahul Buvasaheb Bade - Director
The CIN (Corporate Identification Number) of Lebrahma Lifescience is U85100MH2020PTC342687. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Lebrahma Lifescience is at Plno B17 Parmar Valley Ramgopal Nagar Padegaon, Aurangabad, Maharashtra, India – 431001.
Lebrahma Lifescience was incorporated on 27 July 2020. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Lebrahma Lifescience on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
No. Lebrahma Lifescience has 1 GST registration on record and it is cancelled or inactive.
Lebrahma Lifescience operated in the healthcare industry, in the diagnostic centers and pathology labs segment. It worked in this industry before it was struck off.
The peers of Lebrahma Lifescience by revenue are Sri Krishna Sai Diagnostic and Research Institute Private Limited, Totipotentrx Cell Therapy Private Limited, Sanctus Bio Private Limited, Shri Siddhivinayak Cath Lab Private Limited, Dalhousie Square Medical & Research Centre Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Dipak Tanaji Padwal was appointed as Director on 08 Oct 2021. Manoj Mahadeo Nagargoje was appointed as Director on 08 Oct 2021. Rahul Buvasaheb Bade was appointed as Director on 27 Jul 2020. Lebrahma Lifescience has 4 board changes on record in total.